Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 01, 2023

BUY
$4.45 - $7.57 $2,225 - $3,785
500 New
500 $2,000
Q2 2022

Aug 10, 2022

SELL
$1.92 - $6.28 $890 - $2,913
-464 Closed
0 $0
Q1 2022

May 02, 2022

BUY
$5.07 - $7.2 $2,352 - $3,340
464 New
464 $3,000
Q3 2018

Nov 15, 2018

SELL
$17.73 - $26.69 $14,804 - $22,286
-835 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$10.79 - $24.44 $9,009 - $20,407
835 New
835 $15,000

Others Institutions Holding OMER

About OMEROS CORP


  • Ticker OMER
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,730,000
  • Market Cap $647M
  • Description
  • Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...
More about OMER
Track This Portfolio

Track Signaturefd, LLC Portfolio

Follow Signaturefd, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.